| Trustees | Mrs Michaela M Rees |
Jones | |||
|---|---|---|---|---|---|
| Mr Maunce H Craft |
|||||
| Mr Jonathan S M Craft | |||||
| Mr Percy Beckley | |||||
| Mr Laurence J F Tarlo | |||||
| Mrs R L Craft | (Appointed | 10November | |||
| 2022) | |||||
| Ambassadors | Mrs Cheryl Whitehead | ||||
| Ms Tiffany Chawner | |||||
| Ms Nicola Floyd | |||||
| Mr Julian O'Dell |
|||||
| Patrons | Lord Alliance CBE | ||||
| Harry &Carolyn Black |
|||||
| Barry Boas | |||||
| Roger Cadbury Family |
|||||
| Harold & Daphne Cooper Charitable |
Trust | ||||
| Peter & Marilyn Cooper | |||||
| John Emery | |||||
| Alassandro Dusi |
|||||
| Isabel Ettedgui | |||||
| The Fallon Family |
|||||
| Leonard &Ranee Feinstein | |||||
| Charles & Diane Herlinger | |||||
| Michael & Lottie Hunter | |||||
| Bob Lefroy | |||||
| Bevs Mahm | |||||
| Martin O'Connor |
|||||
| Sir Michael Parkinson | CBE | ||||
| Sir Paul & Lady Ruddock | |||||
| Ivor & Isabelle Seddon | |||||
| Chns Sharp | |||||
| Michaela M Ress Jones |
|||||
| Secretary | Mrs Joyce Fletcher (J.P.) | ||||
| Charity number | 1143743 | ||||
| Company | number | 07767248 | |||
| Principal address | 2 Regency Chambers | ||||
| Jubilee Way | |||||
| Bury | |||||
| Lancashire | |||||
| BL9OJW | |||||
| Registered | office | 2 Regency Chambers | |||
| Jubilee Way | |||||
| Bury | |||||
| Lancashire | |||||
| BL9OJW |
| Page | ||||
|---|---|---|---|---|
| Chairman's | statement | |||
| Trustees' | report | 2-7 | ||
| Statement | ofTrustees' | responsibilities | ||
| Independent auditor's |
report | 9-11 | ||
| Statement | offinancial | actwities | 12-13 | |
| Balance sheet | 14 | |||
| Statement | ofcash flows | 15 | ||
| Notes to the finanaal | statements | 16-24 |
| Unrestricted | Restricted | Total | Total | ||||
|---|---|---|---|---|---|---|---|
| funds | funds | ||||||
| Notes | 2022 f |
2022f | 2022f | 2021f | |||
| Income from: | |||||||
| Voluntary income |
3 | 464,027 | 37,194 | 501,221 | 279,706 | ||
| Investments | 4 | 7,005 | 7,005 | 9,628 | |||
| Total income | 471,032 | 37,194 | 508,226 | 289,334 | |||
| ~Ed i | |||||||
| Raising funds | 5 | 71,907 | 71,907 | 69,459 | |||
| Charitable activities |
6 | 339,665 | 138,067 | 477,732 | 1,028,978 | ||
| Total | 411,572 | 138,067 | 549,639 | 1,098,437 | |||
| Net income/(expenditure) | for the year) | ||||||
| Net movement | in funds | 59,460 | (100,873) | (41,413) | (809,103) | ||
| Fund balances | at 1 October | 2021 | 2,111,856 | 113,150 | 2,225,006 | 3,034,109 | |
| Fund balances | st 30September 2022 | 2,171,316 | 12,277 | 2,183,593 | 2,225,006 |
| Prior financial | year | ||||||
|---|---|---|---|---|---|---|---|
| Unrestricted | Restricted | Total | |||||
| funds | funds | ||||||
| 2021 | 2021 | 2021 | |||||
| Notes | 8 | 8 | |||||
| Income from: | |||||||
| Voluntary income |
226,039 | 53,667 | 279,706 | ||||
| Investments | 9,628 | 9,628 | |||||
| Total income | 235,667 | 53,667 | 289,334 | ||||
| ~Ed i | |||||||
| Raising funds | 5 | 69,459 | 69,459 | ||||
| Chantable activities |
8 | 1,013,959 | 15,019 | 1,028,978 | |||
| Total | 1,083,418 | 15,019 | 1,098,437 | ||||
| Net income/(expenditure) | for the | year/ | |||||
| Net movement | in funds | (847,751) | 38,648 | (809,103) | |||
| Fund balances | at 1 October | 2020 | 2,959,607 | 74,502 | 3,034,109 | ||
| Fund balances | at 30September | 2021 | 2,111,856 | 113,150 | 2,225,006 |
| 2022 | 2021 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Notes | 5 | 6 | |||||||
| Current assets | |||||||||
| Debtors | 391 | 381 | |||||||
| Cash at bank and | in | hand | 2,239,418 | 2,302,991 | |||||
| 2,239,809 | 2,303,372 | ||||||||
| Creditors: | amounts | falling due within | |||||||
| one year | 12 | (56,216) | (78,366) | ||||||
| Net current | assets | 2,183,593 | 2,225,006 | ||||||
| Funds ofthe charity | |||||||||
| Restricted | funds | 13 | 12,277 | 113,150 | |||||
| Unrestncted | funds. | ||||||||
| General unrestncted | funds | 658,197 | 641,903 | ||||||
| Designated | funds | 14 | 1,513,119 | 1,469,453 | |||||
| 2,183,593 | 2,225,006 |
| 2022 | 2021 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Notes | 6 | 6 | |||||||
| Cash flows from operating | activities | ||||||||
| Cash absorbed by operations |
17 | (70,578) | (839,998) | ||||||
| Investing | activities | ||||||||
| Investment | income received | 7,005 | 9,628 | ||||||
| Net cash activities |
generated from |
investing | 7,005 | 9,628 | |||||
| Net cash | used in financing |
activities | |||||||
| Net decrease in cash and |
cash equivalents | (63,573) | (830,370) | ||||||
| Cash and | cash equivalents | at beginning | ofyear | 2,302,991 | 3,133,361 | ||||
| Cash and | cash equivalents | at end of | year | 2,239,418 | 2,302,991 |
| N0 N |
CIC | Ch Yl 0 |
I ID CD ID |
CD 0 Dl |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| N | |||||||||||
| 'D Ot II |
IO CO |
N0 | Ol | IA IA N |
CD 5 |
||||||
| IA | IA | ||||||||||
| IO | |||||||||||
| Ol | |||||||||||
| 'a8 | IO CO |
N0 N |
Ctt | CO CD |
IA IA I |
CO 0 CD N |
|||||
| IO | |||||||||||
| D | |||||||||||
| 80 | N N0 N |
CIC | N N CD |
0 0 0 IAN |
N 0 |
||||||
| IA | |||||||||||
| 'U Ot D |
Ol CO0 I |
N N0 N |
Cll | C CO |
0 0 0 IAN |
CO CA |
|||||
| IO | |||||||||||
| IO | |||||||||||
| CO3 I |
Ol 0 |
N CV0 N |
III | 0 CD |
N 0I CD |
||||||
| IO | |||||||||||
| 0 | IO0 | ||||||||||
| LUI- | |||||||||||
| z0I- z cL'aZ po 0 V) ized |
OlO Nl |
||||||||||
| Ill | |||||||||||
| LU | |||||||||||
| IXI | Cl | ||||||||||
| LUI- —~ cC ~ LUrn z U Ueo Z & I-oz z LL~g ~ Ng LL |
I~ Q. O 0 CI |
CO | Q | ||||||||
| & | g UJ ~z |
L | tO | Qt Dt |
|||||||
| 4~a iOrn LU I- 8- ZUO I- cL'z |
4l 0 |
0 | IO IO0 0 Cl |
Vl tO C tt |
| 4 | Investments | Investments | |||||
|---|---|---|---|---|---|---|---|
| Unrestricted | Unrestricted | ||||||
| funds | funds | ||||||
| 2022 | 2021 | ||||||
| f | |||||||
| Interest receivable | 7,005 | 9,628 | |||||
| 5 | Raising | funds | |||||
| Unrestricted | Unrestricted | ||||||
| funds | funds | ||||||
| 2022f | 2021 5 |
||||||
| Costs of | generating | voluntary | income | ||||
| Travelhng | and subsistence | 112 | |||||
| Printing, | stationery | and postage | 1,091 | 1,130 | |||
| Fundraising expenses |
463 | ||||||
| Other expenses | 298 | 177 | |||||
| Advertising | 475 | 445 | |||||
| Other fundraising | costs | 615 | 266 | ||||
| Staff costs | 67,958 | 66,594 | |||||
| Insurance | 895 | 847 | |||||
| Costs of | generating | voluntary | income | 71,907 | 69,459 |
| Unrestricted | Restricted | TotalUnrestricted | TotalUnrestricted | Restricted | Total | ||
|---|---|---|---|---|---|---|---|
| 2022 | 2022 5 |
2022 6 |
2021 6 |
2021 5 |
2021f | ||
| LMTK3 drug development | 91,781 | 91,781 | 308,789 | 308,789 | |||
| Cancer stem cells research | 100,873 | 100,873 | |||||
| PhD and other student | |||||||
| bursaries | 64,622 | 64,622 | 99,393 | 99,393 | |||
| Ovarian cancer research | 12,627 | 12,627 | 23,094 | 23,094 | |||
| Pancreatic cancer research | 25,238 | 25,238 | 14,808 | 14,808 | |||
| Genetic switches | 66,530 | 66,530 | 134,508 | 134,508 | |||
| Breast cancer research | 73,850 | 37,194 | 111,044 | 428,075 | 15,019 | 443,094 | |
| Other research project | 232 | 232 | |||||
| 334,648 | 138,067 | 472,715 | 1,008,899 | 15,019 | 1,023,918 | ||
| Share ofgovernance | costs | ||||||
| (see note 7) | 5,017 | 5,017 | 5,060 | 5,060 | |||
| 339,665 | 138,067 | 477,732 | 1,013,959 | 15,019 | 1,028,978 | ||
| Analysis by fund |
|||||||
| Unrestricted funds |
339,665 | 339,665 | 1,013,959 | 1,013,959 | |||
| Restricted funds |
138,067 | 138,067 | - | 15,019 | 15,019 | ||
| 339.665 | 138,067 | 477,732 | 1,013,959 | 15,019 | 1,028,978 |
| 2022 | 2021 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Number | Number | ||||||||||||
| Management | |||||||||||||
| Employment | costs | 2022 f |
2021 f |
||||||||||
| Wages and salaries | 64,250 | 62,720 | |||||||||||
| Social secunty | costs | 2,425 | 2,591 | ||||||||||
| Other pension | costs | 1,283 | 1,283 | ||||||||||
| 67,958 | 66,594 | ||||||||||||
| No employees | had annual | remuneration | off60,000or more. | ||||||||||
| Many of the research | proiects | involve the use of PhD students. | Action Against Cancer | is currently | funding a |
||||||||
| number of PhD studentships |
and | fellowships at Imperial |
College | to support the research | work. | ||||||||
| 10 | Taxation | ||||||||||||
| The charity is |
exempt | from | tax | on | income | and gains falling | within | section 505 ofthe | Taxes Act 1988or section | ||||
| 252 ofthe Taxation of | Chargeable | Gains | Act 1992to the | extent that these are applied | to | its charitable objects. | |||||||
| 11 | Debtors | ||||||||||||
| 2022 | 2021 | ||||||||||||
| Amounts falling due |
within one | year: | f | ||||||||||
| Prepayments | and accrued | income | 391 | 381 |
| Creditors: | a | m | oun | ts | falling | due | within o | ne year | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022 | 2021 | ||||||||||||
| E | E | ||||||||||||
| Trade creditors | 54,422 | 76,808 | |||||||||||
| Other creditors | 1,794 | 1,558 | |||||||||||
| 56,216 | 78,366 | ||||||||||||
| Restricted | funds | ||||||||||||
| The income | funds | of the charity | include | restricted | funds | comprising | the following | unexpended | balances of |
||||
| donations | and | grants | held on | trust | for specific purposes: | ||||||||
| Movement | in funds | Movement | in funds | ||||||||||
| Balance at | Income | Expenditure | Balance at | Income | Expenditure | Balance at | |||||||
| 1 October 2020 | 1 October 2021 | 30 September | |||||||||||
| 2022 | |||||||||||||
| E | E | E | |||||||||||
| Cancer stem | |||||||||||||
| cells research | 59,483 | 53,667 | 113,150 | (100,873) | 12,277 | ||||||||
| Breast cancer | |||||||||||||
| research | 15,019 | (15,019) | 37,194 | (37,194) | |||||||||
| 74,502 | 53,667 | (15,019) | 113,150 | 37,194 | (138,067) | 12,277 |
| 15 | Analysis | ofnet assets | between funds | |||||
|---|---|---|---|---|---|---|---|---|
| Unrestricted | Restricted | Total | Unrestricted | Restricted | Total | |||
| funds | funds | funds | funds | |||||
| 2022 | 2022 | 2022 | 2021 | 2021 | 2021 | |||
| 8 | 6 | 6 | F | 6 | ||||
| Fund balances at 30 | ||||||||
| September 2022 are | ||||||||
| represented by: |
||||||||
| Current | assets/(liabilities) | 2,171,316 | 12,277 | 2,183,593 | 2,111,856 | 113,150 | 2,225,006 | |
| 2,171,316 | 12,277 | 2,183,593 | 2,111,856 | 113,150 | 2,225,006 |
| Cash generated from |
operations | 2022 | 2021 | ||||
| 6 | |||||||
| Deficit for the year | (41,413) | (809,103) | |||||
| Adjustments | for: | ||||||
| Investment | income recognised | in statement | of finanaal | activities | (7,005) | (9,628) | |
| Movements | in working | capital. | |||||
| (Increase) | in debtors | (10) | |||||
| (Decrease) | in creditors | (22,150) | (21,267) | ||||
| Cash absorbed by operations |
(70,578) | (839,998) |